FACULTY
Alexis Ogdie-Beatty, MD, MSCE
Associate Professor of Medicine and Epidemiology
University of Pennsylvania
Philadelphia, PA
PROGRAM OVERVIEW
In this series of two podcasts, Dr. Alexis Ogdie will discuss the clinical manifestations of spondyloarthritis in order to differentiate it from other pain-related conditions. This includes discussion of the differences between axial spondyloarthritis and peripheral spondyloarthritis. In addition, Dr. Ogdie will discuss treatment strategies, both novel and conventional, and describe the importance of shared decision-making and multidisciplinary collaboration in pursuing the best treatment outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of rheumatologists, nurse practitioners, and physician assistants to improve knowledge and competence of these healthcare providers regarding the latest evidence in targeted therapies for SpA conditions, and strategies for improving patient-specific, shared decision-making care to advance the optimal outcomes of patients with these debilitating conditions.
LEARNING OBJECTIVES
- Describe the clinical manifestations of SpA conditions to promptly differentiate and diagnose
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Alexis Ogdie discloses that she has received consulting fees from AbbVie, Inc., Amgen, Inc., Bristol-Myers Squibb, Celgene Corporation, CorEvitas, Gilead, Janssen, Kopa/Twill Health, Lilly, Novartis Pharmaceuticals, Pfizer, UCB, and Takeda. In addition, Dr. Ogdie has conducted contracted research for Abbvie (payment to Penn), Novartis Pharmaceuticals (payment to Penn), Pfizer, Inc. (payment to Penn), Amgen (payment to Forward/NDB), NIH/NIAMS, National Psoriasis Foundation, Rheumatology Research Foundation,
and Forward Databank.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Director of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Associate Program Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: January 12, 2024
EXPIRATION DATE: January 12, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Alexis Ogdie-Beatty, MD, MSCE
Associate Professor of Medicine and Epidemiology
University of Pennsylvania
Philadelphia, PA
PROGRAM OVERVIEW
In this series of two podcasts, Dr. Alexis Ogdie will discuss the clinical manifestations of spondyloarthritis in order to differentiate it from other pain-related conditions. This includes discussion of the differences between axial spondyloarthritis and peripheral spondyloarthritis. In addition, Dr. Ogdie will discuss treatment strategies, both novel and conventional, and describe the importance of shared decision-making and multidisciplinary collaboration in pursuing the best treatment outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of rheumatologists, nurse practitioners, and physician assistants to improve knowledge and competence of these healthcare providers regarding the latest evidence in targeted therapies for SpA conditions, and strategies for improving patient-specific, shared decision-making care to advance the optimal outcomes of patients with these debilitating conditions.
LEARNING OBJECTIVES
- Apply the latest clinical evidence for interleukin-17 (IL-17) antagonists for the management of SpA conditions
- Develop strategies to optimize the shared decision-making efforts and collaboration across the multidisciplinary care team in the management of SpA conditions
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Alexis Ogdie discloses that she has received consulting fees from AbbVie, Inc., Amgen, Inc., Bristol-Myers Squibb, Celgene Corporation, CorEvitas, Gilead, Janssen, Kopa/Twill Health, Lilly, Novartis Pharmaceuticals, Pfizer, UCB, and Takeda. In addition, Dr. Ogdie has conducted contracted research for Abbvie (payment to Penn), Novartis Pharmaceuticals (payment to Penn), Pfizer, Inc. (payment to Penn), Amgen (payment to Forward/NDB), NIH/NIAMS, National Psoriasis Foundation, Rheumatology Research Foundation,
and Forward Databank.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Director of Med Learning Group, has nothing to disclose.
- Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
- Jessica Feygin, Associate Program Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
Please listen to the podcast below:
RELEASED DATE: January 12, 2024
EXPIRATION DATE: January 12, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
